The Polycystic Ovary Disease (PCOD) is one of the most common endocrine disorders in women with a prevalence of 5%. Affected women often consult a gynecologist because of menstrual irregularities, fertility problems or problems of androgen excess. However, PCOD is a metabolic disorder affecting multiple organs. Studies suggest that those women are at risk for developing several complications such as type II diabetes mellitus, hypertension, dyslipidemia and myocardial infarction. The risk to develop endometrial carcinoma is also elevated. To give adequate treatment to women with PCOD, an interdisciplinary approach of gynecologists together with endocrinologists specialized in metabolic and nutritional disorders at the University of Basel is presented. The work-up for diagnosis and assessment of risk factors is outlined. Goal of this interdisciplinary approach is an adequate evaluation of affected patients and their long-term follow-up to test if proposed interventions as weight loss, treatment of hyperinsulinemia, regulation of menstrual cycle and others can avoid long-term sequelae.
Recent diagnostic and pharmacologic developments have focused renewed attention on polycystic ovary syndrome. Clinical features of the syndrome include anovulation, hyperandrogenism and menstrual dysfunction, but several other abnormalities, including hyperinsulinemia, luteinizing hormone hypersecretion, elevated testosterone levels and acyclic estrogen production, have been documented. Accompanying obesity and lipid abnormalities compound the risk of developing diabetes mellitus or cardiovascular disease, and chronic anovulation increases the risk for endometrial cancer. A careful history and physical examination should guide diagnostic testing. Slowly progressive hyperandrogenic symptoms with anovulation of peripubertal onset often represent polycystic ovary syndrome. Treatment goals include symptom management and the identification and prevention of potential cardiovascular risks. Treatment should take into account the patient's desire for fertility. Advances in transvaginal ultrasonography and infertility treatments, including newer medications, have facilitated assisted reproduction in patients with polycystic ovary syndrome. Ongoing pharmacologic research focusing on the treatment of insulin resistance appears promising in reversing the longterm complications of the syndrome.
Fertility AwarenessComparative EffectivenessRisks and LimitationsBasal Body Temperature
Risks of 5 natural family planning (NFP) methods are compared. The main risk of these methods is the risk of pregnancy stemming from method failure, errors in instruction, error in application of the method, and failure to observe abstinence during the entire fertile period. The calendar rhythm method, the oldest NFP method, is based on calculation of likely fertile days in the preceding 6-12 menstrual cycles. The method is seldom taught at present because of its high failure rate, but it continues to be used, often by individuals with an incomplete understanding of the calculations. The principle of the basal body temperature method is well known. The thermal shift affirms the beginning of the infertile period but does not allow prediction of ovulation. Instructions provided by different organizations to identify the third day of the hyperthermal plateau are not standardized; the various interpretations applied to the same cycle do not necessarily lead to identification of the same day as the start of the infertile period. Comparisons of efficacy between methods are therefore difficult. Well-conducted prospective studies have demonstrated high theoretical efficacy, but failure rates in practice appear to be higher. Women often do not know how to interpret a temperature curve correctly, and the curve may be influenced by illness, sleeping late, a change of life style or thermometer. Some authors have reported that 3-20% of ovulatory cycles have monophasic temperature curves. The temperature method requires lengthy abstinence lasting until the third day of higher temperature, which may create conflicts in some couples. To ease the difficulties of interpretation of the temperature method, a Swiss architect developed an electronic thermometer programmed according to rules of the calendar rhythm method for cycles of 19-39 days. The woman's 6 most recent cycle lengths remain in the memory to indicate probable infertile days. Although no formal evaluations have appeared in the literature on the Bioself thermometer, the method appears to entail risks including registration of incorrect temperature due to humidity or rundown batteries, and inadequate programming to identify the safe period. The Billings or cervical mucus method is based on observation by the woman of the thickness, wetness, and other characteristics of mucus secretions in the vulva to predict ovulation. Various studies have shown high theoretical efficacy but practical efficacy is lower. Vaginal infections, some ovarian pathologies, and postpartum hormonal changes are among factors that can alter mucus patterns. The method does not confirm ovulation, and false "peak days" may occur. The symptothermal method is based on all the principles of the cervical mucus and temperature methods as well as autopalpation of the cervix and any other signs of ovulation. Effectiveness rates are high. In general pregnancy risks are the same as those for the cervical mucus and temperature methods. A theoretical heightened risk of abortion or fetal malformation common to all the methods due to fertilization of aging gametes has not been definitively evaluated. Another possible risk results from timing of abstinence at the phase of the menstrual cycle when the woman's sexual desire is likely to be greatest.